Europe
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
Regeneron will distribute REGN-COV-2 in the U.S. and Roche will handle distribution outside the U.S.
The legal ruling, subject to appeal, protects the Swiss pharma giant’s revenue stream from the blockbuster drug Gilenya for a little bit longer.
“Joining the board will allow me to help guide and influence the development of a product from bench to bedside,” Franchimont told BioSpace. “I look forward to contributing to ongoing discussions on translation from bench science to the clinic, and ultimately to making real differences in the lives of patients.”
The new research hub will be called the London Discovery Research Centre and is expected to open by 2025.
Together the two companies will scour comprehensive medical and molecular data sets of thousands of chronic kidney disease patients to identify and then develop possible drugs.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 19, 2020.
Under terms of the deal, Sanofi will acquire all of the outstanding shares of Principia for $100 per share in cash, which represents an aggregate equity value of approximately $3.68 billion.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 17, 2020.
PRESS RELEASES